4.7 Article

Selection of mutants with resistance or diminished susceptibility to ceftazidime/avibactam from ESBL-and AmpC-producing Enterobacteriaceae

期刊

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 73, 期 12, 页码 3336-3345

出版社

OXFORD UNIV PRESS
DOI: 10.1093/jac/dky363

关键词

-

资金

  1. AstraZeneca

向作者/读者索取更多资源

Introduction: Difficult Gram-negative infections are increasingly treated with new beta-lactamase inhibitor combinations, e.g. ceftazidime/avibactam. Disturbingly, mutations in KPC carbapenemases can confer ceftazidime/avibactam resistance, which is sometimes selected during therapy. We explored whether this risk extended to AmpC and ESBL enzymes. Methods: Mutants were selected by plating AmpC-derepressed strains, ESBL producers and ceftazidimesusceptible controls on agar containing ceftazidime + avibactam (1 or 4 mg/L). MICs were determined by CLSI agar dilution; WGS was by Illumina methodology. Results: Using 2x MIC of ceftazidime + 1 mg/L avibactam, mutants were selected from all strain types at frequencies of 10(-7)-10(-9). Rates diminished to <10(-9) with 4 mg/L avibactam or higher MIC multiples, except with AmpC-derepressed Enterobacteriaceae. Characterized mutants (n = 10; MICs 4-64 mg/L) of AmpC-derepressed strains had modifications in ampC, variously giving Arg168Pro/His, Gly176Arg/Asp, Asn366Tyr or small deletions around positions 309-314. Mutants of ESBL producers (n = 19; MICs 0.5-16 mg/L) mostly had changes affecting permeability, efflux or beta-lactamase quantity; only one had an altered beta-lactamase, with an Asp182Tyr substitution in CTX-M-15, raising the ceftazidime/avibactam MIC, but abrogating other cephalosporin resistance. Mutants of ceftazidime-susceptible strains were not sequenced, but phenotypes suggested altered drug accumulation or, for Enterobacter cloacae only, AmpC derepression. In further experiments, avibactam reduced, but did not abolish, selection of AmpC-derepressed Enterobacteriaceae by ceftazidime. Conclusions: Most mutants of AmpC-derepressed Enterobacteriaceae had structural mutations in ampC; those of ESBL producers mostly had genetic modifications outside beta-lactamase genes, commonly affecting uptake, efflux, or beta-lactamase quantity. The clinical significance of these observations remains to be determined.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Clonal expansion of community-associated meticillin-resistant Staphylococcus aureus (MRSA) in people who inject drugs (PWID): prevalence, risk factors and molecular epidemiology, Bristol, United Kingdom, 2012 to 2017

Simon Packers, Bruno Pichon, Stephen Thompson, Jane Neale, Jacquelyn Njoroge, Rachel M. Kwiatkowska, Isabel Oliver, Maggie Telfer, Michel Doumith, Camillus Buunaaisie, Ellen Heinsbroek, Noreen Hopewell-Kelly, Monica Desai, Vivian Hope, Owen Martin Williams, Angela Kearns, Mathew Hickman, Maya Gobin

EUROSURVEILLANCE (2019)

Article Infectious Diseases

Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Campylobacter jejuni and Campylobacter coli isolated from cases of diarrhoeal disease in England and Wales, 2015-16

Anais Painset, Martin Day, Michel Doumith, Jonathan Rigby, Claire Jenkins, Kathie Grant, Timothy J. Dallman, Gauri Godbole, Craig Swift

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Article Public, Environmental & Occupational Health

Genomic analysis of the first KPC-producing Klebsiella pneumoniae isolated from a patient in Riyadh: A new public health concern in Saudi Arabia

Majed F. Alghoribi, Khalifa Binkhamis, Abdulrahman A. Alswaji, Ali Alhijji, Aynaa Alsharidi, Hanan H. Balkhy, Michel Doumith, Ali Somily

JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)

Article Genetics & Heredity

The characterization of mobile colistin resistance (mcr) genes among 33 000 Salmonella enterica genomes from routine public health surveillance in England

Cheryll M. Sia, David R. Greig, Martin Day, Hassan Hartman, Anais Painset, Michel Doumith, Daniele Meunier, Claire Jenkins, Marie Anne Chattaway, Katie L. Hopkins, Neil Woodford, Gauri Godbole, Timothy J. Dallman

MICROBIAL GENOMICS (2020)

Letter Infectious Diseases

OXA-48 carbapenemase-producing Salmonella enterica serovar Kentucky ST198 isolated from Saudi Arabia

Majed F. Alghoribi, Taseen S. Desin, Abdulrahman A. Alswaji, Bassam H. Al Alwan, Maha Alzayer, Liliane Okdah, Sameera Al Johani, Hanan H. Balkhy, Michel Doumith

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Article Infectious Diseases

Activity of β-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria

Shazad Mushtaq, Anna Vickers, Michel Doumith, Matthew J. Ellington, Neil Woodford, David M. Livermore

Summary: Taniborbactam potentiates partner beta-Lactams against various Enterobacterales with different carbapenemases, showing potential broader spectrum compared to vaborbactam.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Multidisciplinary Sciences

Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam

Majed F. Alghoribi, Moayad Alqurashi, Liliane Okdah, Bassam Alalwan, Yahya S. AlHebaishi, Abdulmajeed Almalki, Maha A. Alzayer, Abdulrahman A. Alswaji, Michel Doumith, Mazin Barry

Summary: The challenging Pandrug-resistant K. pneumoniae infection can be successfully overcome and cleared rapidly through testing different drug combinations.

SCIENTIFIC REPORTS (2021)

Article Microbiology

Genomic Characterization of Carbapenem-Non-susceptible Pseudomonas aeruginosa Clinical Isolates From Saudi Arabia Revealed a Global Dissemination of GES-5-Producing ST235 and VIM-2-Producing ST233 Sub-Lineages

Michel Doumith, Sarah Alhassinah, Abdulrahman Alswaji, Maha Alzayer, Essa Alrashidi, Liliane Okdah, Sameera Aljohani, Hanan H. Balkhy, Majed F. Alghoribi

Summary: Carbapenem-resistant P. aeruginosa is a major clinical problem in Saudi Arabia. This study provides insights into the genetic characteristics and antibiotic resistance mechanisms of these clinical isolates, highlighting the global spread of specific sub-lineages. It emphasizes the importance of routine detection of rare beta-lactamases.

FRONTIERS IN MICROBIOLOGY (2022)

Article Medicine, Research & Experimental

Invasive fungal infection of the brain caused by Neoscytalidium dimidiatum in a post-renal transplant patient: A case report

Maha Alamri, Heba Alghamdi, Sahar Althawadi, Maysoon Mutabaggani, M. Anas Dababo, Fahad Alajlan, Maha Alzayer, Michel Doumith, Majed Alghoribi, Reem S. Almaghrabi

Summary: Neoscytalidium is a plant pathogen commonly found in plants and soil, causing skin and nail infections as well as invasive diseases in immunocompromised patients. Despite combined surgical and medical therapies, treating invasive fungal diseases caused by Neoscytalidium can be challenging and often result in fatal outcomes.

MEDICAL MYCOLOGY CASE REPORTS (2021)

Article Microbiology

Diversity of carbapenemase-producing Enterobacterales in England as revealed by whole-genome sequencing of isolates referred to a national reference laboratory over a 30-month period

Katie L. Hopkins, Nicholas Ellaby, Matthew J. Ellington, Michel Doumith, Nazim Mustafa, Daniele Meunier, Neil Woodford

Summary: By sequencing CPE samples from the national reference laboratory in England, we found that the epidemiology of CPE in England is diverse, indicating multiple introductions and a role for horizontal transfer of carbapenemase genes.

JOURNAL OF MEDICAL MICROBIOLOGY (2022)

Article Infectious Diseases

In vitro activity of cefiderocol against clinically important carbapenem non-susceptible Gram-negative bacteria from Saudi Arabia

Maha Alzayer, Majed F. Alghoribi, Bassam Alalwan, Abdualah Alreheli, Sameera Aljohani, Mohammad Bosaeed, Michel Doumith

Summary: This study investigated the in vitro activity of Cefiderocol against carbapenem non-susceptible Gram-negative bacteria collected in Saudi Arabia. The results showed that Cefiderocol exhibited excellent activity, especially against multidrug-resistant non-fermenting Gram-negative pathogens.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2023)

Article Infectious Diseases

Molecular typing and antimicrobial resistance of group B Streptococcus clinical isolates in Saudi Arabia

Maha Alzayer, Manal M. Alkhulaifi, Ahmed Alyami, Mohammed Aldosary, Abdulaziz Alageel, Ghada Garaween, Atef Shibl, Arif M. Al-Hamad, Michel Doumith

Summary: Group B Streptococcus (GBS) has emerged as an important cause of severe infections in adults. This study investigated the epidemiology of GBS in Saudi Arabia and found that serotypes III and V were the most prevalent, and most isolates harbored pilus island 1 and 2a types. The isolates exhibited high levels of resistance to erythromycin and clindamycin, which require further surveillance.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2023)

Article Infectious Diseases

Acquired resistome and plasmid sequencing of mcr-1 carrying MDR Enterobacteriaceae from poultry and their relationship to STs associated with humans

Antoine Abou Fayad, Maria El Azzi, Ahmad Sleiman, Issmat I. Kassem, Reema A. Bawazeer, Liliane Okdah, Michel Doumith, Majed F. Alghoribi, Ghassan M. Matar

Summary: The study revealed the presence of mcr and other important resistance determinants in MDR E. coli isolated from poultry farms in Lebanon, with resistance genes predominantly located on IncX4 plasmids. Some strains may pose a risk of transmission to humans.

JAC-ANTIMICROBIAL RESISTANCE (2021)

Article Microbiology

Complete Genome Sequence of a Colistin-Resistant Uropathogenic Escherichia coli Sequence Type 131 fimH22 Strain Harboring mcr-1 on an lncHI2 Plasmid, Isolated in Riyadh, Saudi Arabia

Majed F. Alghoribi, Michel Doumith, Mathew Upton, Sameera M. Al Johani, Maha Alzayer, Neil Woodford, Matthew J. Ellington, Hanan H. Balkhy

MICROBIOLOGY RESOURCE ANNOUNCEMENTS (2019)

Article Infectious Diseases

OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli

David M. Livermore, Michaela Day, Paul Cleary, Katie L. Hopkins, Mark A. Toleman, David W. Wareham, Camilla Wiuff, Michel Doumith, Neil Woodford

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

暂无数据